ImmunityBio Competitors and Similar CompaniesClear all
MABION's competitors and similar companies include Sonnet BioTherapeutics.
 MABION Mabion is a biotechnology company engaged in research and development of biotechnology and biosimilar drugs to treat cancer, autoimmune, and metabolic diseases. |  Sonnet BioTherapeutics Sonnet BioTherapeutics (formerly known as Chanticleer Holdings) is an oncology-focused biotechnology company. | |
Founding Date | Founding Date 2007 | Founding Date 2011 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Konstantynów Łódzki, PL HQ | Locations Princeton, US HQ |
Employees | Employees 95 | Employees 12 |
Valuation ($) | Valuation ($) 21.7 m | Valuation ($) 2.9 m |
Financial | ||
Revenue (est.) | Revenue (est.) zł15.8m (FY, 2025) | Revenue (est.) $1m (FY, 2025) |
Net income | Net income (zł62.6m) (FY, 2025) | Net income ($16m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Sonnet BioTherapeutics
HQ
Princeton, US
Employees
12
Sonnet BioTherapeutics (formerly known as Chanticleer Holdings) is an oncology-focused biotechnology company.
View company